T-cell receptor signaling and the pathogenesis of autoimmune arthritis: Insights from mouse and man

Immunology and Cell Biology

Volumn 90, Issue 3, 2012, Pages 277-287

  Sakaguchi, Shimon ^a,b   Benham, Helen ^c   Cope, Andrew P ^d   Thomas, Ranjeny ^c  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

innate immunity; rheumatoid arthritis; spondyloarthropathy; T cell receptor

Indexed keywords

CD40 ANTIGEN; DECTIN 1; HLA DR4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23 RECEPTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ADAPTIVE IMMUNITY; ANKYLOSING SPONDYLITIS; CONFERENCE PAPER; CROHN DISEASE; DENDRITIC CELL; EFFECTOR CELL; ENTERITIS; GENETIC ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOARTHROPATHY; T LYMPHOCYTE ACTIVATION; TH17 CELL; TREATMENT RESPONSE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; MICE; MICE, MUTANT STRAINS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 84858695978     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.4     Document Type: Conference Paper

References (118)

1. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
2. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76: 263-274. (Pubitemid 24046689)
3. Gelfand EW, Weinberg K, Mazer BD, Kadlecek TA, Weiss A. Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes. J Exp Med 1995; 182: 1057-1065.
4. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994; 264: 1599-1601. (Pubitemid 24227717)
5. Rieux-Laucat F, Hivroz C, Lim A, Mateo V, Pellier I, Selz F et al. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N Engl J Med 2006; 354: 1913-1921. (Pubitemid 43872692)
6. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007; 130: 25-35. (Pubitemid 47031326)
7. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-460. (Pubitemid 37490133)
8. Siggs OM, Miosge LA, Yates AL, Kucharska EM, Sheahan D, Brdicka T et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 2007; 27: 912-926. (Pubitemid 350251221)
9. Thomas R, Turner M, Cope AP. High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: Central to rheumatoid arthritis pathogenesis? Arthritis Res Ther 2008; 10: 210.
10. Emery P, Panayi G, Symmons D, Brown G. Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: The role of protein energy malnutrition. Ann Rheum Dis 1984; 43: 430-434. (Pubitemid 14117918)
11. Emery P, Panayi GS, Nouri AM. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis. Clin Exp Immunol 1984; 57: 123-129. (Pubitemid 14083836)
12. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigenpresenting dendritic cells. J Immunol 1994; 152: 2613-2623. (Pubitemid 24097956)
13. Cope AP, Londei M, Chu NR, Cohen SB, Elliott MJ, Brennan FM et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 1994; 94: 749-760.
14. 4+ T cells in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 2166-2173. (Pubitemid 30263601)
15. Lorenz HM, Antoni C, Valerius T, Repp R, Grunke M, Schwerdtner N et al. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 1996; 156: 1646-1653.
16. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
17. Zhu L, Ji F, Wang Y, Zhang Y, Liu Q, Zhang JZ et al. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J Immunol 2006; 177: 8226-8233. (Pubitemid 44846344)
18. Holoshitz J, Ling S. Nitric oxide signaling triggered by the rheumatoid arthritis shared epitope: A new paradigm for MHC disease association? Ann NY Acad Sci 2007; 1110: 73-83. (Pubitemid 350042997)
19. Summers KL, O' Donnell JL, Heiser A, Highton J, Hart DN. Synovial fluid transforming growth factor beta inhibits dendritic cell- T lymphocyte interactions in patients with chronic arthritis. Arthritis Rheum 1999; 42: 507-518. (Pubitemid 29136099)
20. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M et al. The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology 2002; 41: 793-800. (Pubitemid 34822963)
21. Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ. Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem 2002; 277: 46940-46949. (Pubitemid 36159198)
22. Schonland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003; 100: 13471-13476. (Pubitemid 37444766)
23. Eisenbraun MD, Tamir A, Miller RA. Altered composition of the immunological synapse in an anergic, age-dependent memory T cell subset. J Immunol 2000; 164: 6105-6112. (Pubitemid 30408786)
24. Fulop Jr T, Gagne D, Goulet AC, Desgeorges S, Lacombe G, Arcand M et al. Agerelated impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex. Exp Gerontol 1999; 34: 197-216. (Pubitemid 29153018)
25. Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol 2002; 2: 487-498. (Pubitemid 37328740)
26. Purvis HA, Stoop JN, Mann J, Woods S, Kozijn AE, Hambleton S et al. Low strength Tcell activation promotes Th17 responses. Blood 2010; 116: 4829-4837.
27. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al. Genomewide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-514.
28. Cope AP, Patel SD, Hall F, Congia M, Hubers HA, Verheijden GF et al. Tcell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum 1999; 42: 1497-1507. (Pubitemid 30265609)
29. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008; 205: 967-979. (Pubitemid 351549891)
30. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1 *0401 MHC class II molecule. J Immunol 2003; 171: 538-541. (Pubitemid 36871358)
31. Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50: 1117-1121. (Pubitemid 38480821)
32. Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum 2006; 54: 3423-3432. (Pubitemid 44737154)
33. Ling S, Pi X, Holoshitz J. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J Immunol 2007; 179: 6359-6367.
34. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337. (Pubitemid 38943877)
35. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EWet al. Replication of putative candidate-gene associations with rheumatoid arthritis in44,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060. (Pubitemid 41698524)
36. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189: 111-121. (Pubitemid 29047031)
37. Diaz-Gallo L-M, Espino-Paisán L, Fransen K, Gómez- García M, van Sommeren S, Cardeña C et al. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2011; 17: 2287-2294.
38. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett 2011; 585: 3689-3698.
39. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004; 303: 685-689. (Pubitemid 38141637)
40. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P et al. Autoimmuneassociated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317-1319. (Pubitemid 41722185)
41. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 2011; 43: 902-907.
42. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007; 179: 4704-4710.
43. Zikherman J, Hermiston M, Steiner D, Hasegawa K, Chan A, Weiss A. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a nonautoimmune background. J Immunol 2009; 182: 4093-4106.
44. Menard L, Saadoun D, Isnardi I, Ng Y-S, Meyers G, Massad C et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 2011; 121: 3635-3644.
45. Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, Franke L et al. Metaanalysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS genetics 2011; 7: E1002004.
46. Dustin ML, Depoil D. New insights into the T cell synapse from single molecule techniques. Nat Rev Immunol 2011; 11: 672-684.
47. Gorman CL, Russell AI, Zhang Z, Cunninghame Graham D, Cope AP, Vyse TJ. Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls. J Immunol 2008; 180: 1060-1070.
48. Tanaka S, Maeda S, Hashimoto M, Fujimori C, Ito Y, Teradaira S et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J Immunol 2010; 185: 2295-2305.
49. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007; 204: 41-47. (Pubitemid 46148754)
50. 4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969-1980. (Pubitemid 28566059)
51. Hsu L-Y, Tan YX, Xiao Z, Malissen M, Weiss A. A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J Exp Med 2009; 206: 2527-2541.
52. Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 2005; 201: 949-960. (Pubitemid 40524464)
53. Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, Akizuki S et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 2010; 207: 1135-1143.
54. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y et al. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 2004; 114: 582-588. (Pubitemid 39572108)
55. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67. (Pubitemid 28041923)
56. Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP et al. Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum 2011; 63: 939-948.
57. Kavanaugh A, Menter A, Mendelsohn A, Shen Y-K, Lee S, Gottlieb AB. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: A randomized, placebo-controlled, phase II trial. Curr Med Res Opin 2010; 26: 2385-2392.
58. Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S et al. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008; 135: 1130-1141.
59. Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebocontrolled, proof-of-concept study. Arthritis Rheum 2010; 62: 929-939.
60. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010; 2: 52ra72.
61. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-257.
62. Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, van den Berg WB et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 2001; 44: 2413-2424. (Pubitemid 32977511)
63. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis 2003; 62: 983-990. (Pubitemid 37159498)
64. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91: 8562-8566. (Pubitemid 24273704)
65. Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A et al. Low T cell production of TNF alpha and IFN gamma in ankylosing spondylitis: Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001; 60: 36-42. (Pubitemid 32038951)
66. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-1957. (Pubitemid 38032126)
67. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748. (Pubitemid 36227625)
68. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon- gamma dysregulation. Arthritis Rheum 2008; 58: 1640-1649. (Pubitemid 351847516)
69. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337. (Pubitemid 350041542)
70. Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123-127.
71. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007; 8: 630-638. (Pubitemid 46785127)
72. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL et al. Susceptibility to ankylosing spondylitis in twins: The role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823-1828. (Pubitemid 27452533)
73. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 2009; 10: 203-213.
74. Bonifazi P, Zelante T, D'Angelo C, De Luca A, Moretti S, Bozza S et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2009; 2: 362-374.
75. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699-5708. (Pubitemid 34556153)
76. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240. (Pubitemid 40189432)
77. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci 2010; 107: 17698-17703.
78. Zhao G, Feng X, Na A, Yongqiang J, Cai Q, Kong J et al. Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers. J Dermatol 2005; 32: 91-96. (Pubitemid 40410297)
79. Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106-2112.
80. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490-500.
81. Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R et al. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 2011; 13: R95.
82. Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, Caòete JD et al. IL-17 positive mast cells contribute to synovial inflammation in spondyloarthritis. Arthritis Rheum 2011; 64: 99-109.
83. Repo H, Koivuranta-Vaara P, Leirisalo-Repo M. Polymorphonuclear leucocyte function and previous yersinia arthritis: Correlation of enhanced superoxide production with late manifestations. Ann Rheum Dis 1988; 47: 452-457.
84. Repo H, Leirisalo M, Tiilikainen A, Laitinen O. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA-B27 positive and negative sera. Arthritis Rheum 1982; 25: 655-661.
85. Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M et al. Enrichment of circulating IL-17-secreting IL-23 receptor-positive gd T cells in patients with active ankylosing spondylitis. Arthritis Rheum 2011 (e-pub ahead of print 5 December 2011; doi:10.1002/art.33507).
86. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 1647-1656.
87. Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008; 58: 2307-2317.
88. Romero-Sanchez C, Tsou HK, Jan MS, Wong RH, Chang IC, Londono J et al. Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain. J Spinal Disord Tech 2010; 24: 202-207.
89. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009; 60: 955-965.
90. 8+ human T-cell functional responses. Proc Natl Acad Sci USA 2011; 108: 9560-9565.
91. Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010; 233: 162-180.
92. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-a production. J ExpMed 2005; 202: 135-143. (Pubitemid 41002916)
93. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-1112. (Pubitemid 120034950)
94. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-2643.
95. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42: 985-990.
96. Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43: 761-767.
97. Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 2011; 108: 7745-7750.
98. Fujikado N, Saijo S, Yonezawa T, Shimamori K, Ishii A, Sugai S et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med 2008; 14: 176-180. (Pubitemid 351214549)
99. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-398. (Pubitemid 29165293)
100. Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008; 205: 331-337. (Pubitemid 351281599)
101. Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R, Oshima S et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 2011; 12: 1184-1193.
102. Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K et al. Beta-glucan triggers spondyloarthropathy and Crohn's-like ileitis in SKG mice. Arthritis Rheum 2012 (e-pub ahead of print 10 February 2012; doi:10.1002/art.34423).
103. Klunker S, Chong MMW, Mantel P-Y, Palomares O, Bassin C, Ziegler M et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med 2009; 206: 2701-2715.
104. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9: 59-70. (Pubitemid 28361295)
105. Jacques P, Venken K, Van Beneden K, Hammad H, Seeuws S, Drennan MB et al. Invariant natural killer T cells are natural regulators of murine spondylarthritis. Arthritis Rheum 2010; 62: 988-999.
106. Wang K, Baldassano R, Zhang H, Qu H-Q, Imielinski M, Kugathasan S et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010; 19: 2059-2067.
107. Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Díaz-Gallo LM, Gómez-García M et al. CD40: Novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One 2010; 5: E11520.
108. Singh K, Deshpande P, Pryshchep S, Colmegna I, Liarski V, Weyand CM et al. ERKdependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol 2009; 183: 8258-8267.
109. Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tak PP, Breedveld FC et al. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 1997; 159: 2973-2978. (Pubitemid 127681320)
110. Zhang Z, Gorman CL, Vermi AC, Monaco C, Foey A, Owen S et al. TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood 2007; 109: 4328-4335. (Pubitemid 46743400)
111. de Launay D, van de Sande MG, de Hair MJ, Grabiec AM, van de Sande GP, Lehmann KA et al. Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): A prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets. Ann Rheum Dis 2011; 71: 415-423.
112. Gringhuis SI, Papendrecht-Van Der Voort EA, Leow A, Nivine Levarht EW, Breedveld FC, Verweij CL. Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol 2002; 22: 400-411. (Pubitemid 34027486)
113. Goronzy JJ, Weyand CM. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 2001; 22: 251-255. (Pubitemid 32667512)
114. Maurice MM, Nakamura H, van der Voort EA, van Vliet AI, Staal FJ, Tak PP et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997; 158: 1458-1465. (Pubitemid 127469974)
115. Remans PH, Gringhuis SI, van Laar JM, Sanders ME, Papendrecht-van der Voort EA, Zwartkruis FJ et al. Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J Immunol 2004; 173: 920-931. (Pubitemid 38924265)
116. Abreu JR, Grabiec AM, Krausz S, Spijker R, Burakowski T, Maslinski W et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling. J Immunol 2009; 183: 621-630.
117. Weyand CM, Fujii H, Shao L, Goronzy JJ. Rejuvenating the immune system in rheumatoid arthritis. Nat rev Rheumatol 2009; 5: 583-588.
118. Fulop Jr T, Larbi A, Dupuis G, Pawelec G. Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - A biochemical paradigm for the ageing immune system. Arthritis Res Ther 2003; 5: 290-302. (Pubitemid 37407979)